AARD ALERT: Securities Fraud Class Action Launched Against Aardvark Therapeutics, Inc. – October 13, 2026 Deadline
Levi & Korsinsky, LLP announced a securities class action filed on behalf of investors who purchased or acquired Aardvark Therapeutics (NASDAQ: AARD) securities. The putative class covers buyers of AARD common stock traceable to the February 13, 2025 IPO and/or purchasers between February 13, 2025 and May 14, 2026, with an October 13, 2026 deadline flagged for prospective lead plaintiffs. The complaint alleges defendants misrepresented ARD-101's safety and overstated its clinical, regulatory, and commercial prospects, rendering offering documents materially misleading.
Key figures
- Ipo date
- 2025-02-13
- Class period end
- 2026-05-14
- Class period start
- 2025-02-13
- Plaintiff deadline
- 2026-10-13
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.